Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biomerica Inc
(NQ:
BMRA
)
5.550
USD
+0.050 (+0.91%)
Streaming Delayed Price
Updated: 3:14 PM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Biomerica Inc
< Previous
1
2
3
4
Next >
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
January 15, 2021
From
GlobeNewswire News Releases
Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
January 12, 2021
From
GlobeNewswire News Releases
Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment
December 09, 2020
From
GlobeNewswire News Releases
Biomerica Reports Fiscal 2021 1st Quarter Financial Results
October 16, 2020
From
GlobeNewswire News Releases
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results
September 01, 2020
From
GlobeNewswire News Releases
Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors
August 31, 2020
From
GlobeNewswire News Releases
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
August 12, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in BioNTech, Endeavour Silver Corp, Biomerica, Heat Biologics, or Tonix Pharmaceuticals?
July 22, 2020
InvestorsObserver issues critical PriceWatch Alerts for BNTX, EXK, BMRA, HTBX, and TNXP.
From
PR Newswire
Biomerica Announces Filing of New Three Year Shelf Registration Statement
July 22, 2020
From
GlobeNewswire News Releases
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
June 29, 2020
From
GlobeNewswire News Releases
Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19
June 16, 2020
From
GlobeNewswire News Releases
Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial
June 01, 2020
From
GlobeNewswire News Releases
Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution
May 07, 2020
From
GlobeNewswire News Releases
Biomerica Announces Third Quarter Financial Results
April 15, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Biomerica, Co-Diagnostics, Ford, Overstock.com, or Tilray?
April 02, 2020
InvestorsObserver issues critical PriceWatch Alerts for BMRA, CODX, F, OSTK, and TLRY.
From
PR Newswire
Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs
April 02, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Blue Apron, BJs Wholesale Club, Biomerica, Cronos Group, or Logitech?
March 19, 2020
InvestorsObserver issues critical PriceWatch Alerts for APRN, BJ, BMRA, CRON, and LOGI.
From
PR Newswire
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
March 17, 2020
From
GlobeNewswire News Releases
Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund
February 26, 2020
From
GlobeNewswire News Releases
Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter
January 15, 2020
From
GlobeNewswire News Releases
Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial
January 07, 2020
From
GlobeNewswire News Releases
Biomerica Reports 1st Quarter Fiscal 2020 Financials
October 16, 2019
From
GlobeNewswire News Releases
Biomerica Announces Fiscal Year End 2019 Financial Results
August 30, 2019
From
GlobeNewswire News Releases
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
August 21, 2019
Biomerica also adds new director of sales and marketing for Europe and South America
From
GlobeNewswire News Releases
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million
June 05, 2019
MaxHealth to distribute Biomerica’s colorectal screening test to help identify the early warning signs of colorectal cancer.
From
GlobeNewswire News Releases
New Research: Key Drivers of Growth for Quintana Energy Services, ProQR Therapeutics N.V, Tetraphase Pharmaceuticals, Biomerica, Heat Biologics, and Bellerophon Therapeutics — Factors of Influence, Ma
April 18, 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Quintana Energy Services Inc....
From
GlobeNewswire News Releases
Biomerica Announces Third Quarter Financial Results
April 16, 2019
Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $4,034,822 for the nine months ending February 28, 2019, compared to $4,433,785 for the period ended February 28, 2018. Sales for the three...
From
GlobeNewswire News Releases
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
April 08, 2019
– New Allowance by U.S. Patent and Trademark Office Includes irritable bowel syndrome (IBS) test kit panel –
From
GlobeNewswire News Releases
Biomerica Announces Updates for H. Pylori Clinical Studies
February 05, 2019
Biomerica Inc. (NASDAQ: BMRA) announced today regulatory and clinical advancements in its development program for its H. pylori diagnostic product.
From
GlobeNewswire News Releases
Biomerica Announces Second Quarter Financial Results
January 15, 2019
Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,500,791 for the three months ended November 30, 2018, compared to $1,613,636 for the same period in the previous year. Net sales were...
From
GlobeNewswire News Releases
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.